Drake CG - Search Results

1

Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition.

Mao W, Ghasemzadeh A, Freeman ZT, Obradovic A, Chaimowitz MG, Nirschl TR, McKiernan E, Yegnasubramanian S, Drake CG. Mao W, et al. Among authors: drake cg. J Immunother Cancer. 2019 Oct 25;7(1):277. doi: 10.1186/s40425-019-0758-y. J Immunother Cancer. 2019. PMID: 31653272 Free PMC article.

2

Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Drake CG, Doody AD, Mihalyo MA, Huang CT, Kelleher E, Ravi S, Hipkiss EL, Flies DB, Kennedy EP, Long M, McGary PW, Coryell L, Nelson WG, Pardoll DM, Adler AJ. Drake CG, et al. Cancer Cell. 2005 Mar;7(3):239-49. doi: 10.1016/j.ccr.2005.01.027. Cancer Cell. 2005. PMID: 15766662 Free PMC article.

3

Eleventh Prouts Neck Meeting on Prostate Cancer: emerging strategies in prostate cancer therapy.

Keller ET, Rowley DR, Tomlins SA, Drake CG, Kantoff PW, Pienta KJ, Montie JE, Carter HB, Hruszkewicz AM, Gomez J, Mohla S, Getzenberg RH. Keller ET, et al. Among authors: drake cg. Cancer Res. 2007 Oct 15;67(20):9613-5. doi: 10.1158/0008-5472.CAN-07-1529. Epub 2007 Oct 10. Cancer Res. 2007. PMID: 17928375 No abstract available.

4

Radiotherapy augments the immune response to prostate cancer in a time-dependent manner.

Harris TJ, Hipkiss EL, Borzillary S, Wada S, Grosso JF, Yen HR, Getnet D, Bruno TC, Goldberg MV, Pardoll DM, DeWeese TL, Drake CG. Harris TJ, et al. Among authors: drake cg. Prostate. 2008 Sep 1;68(12):1319-29. doi: 10.1002/pros.20794. Prostate. 2008. PMID: 18561247 Free PMC article.

5

Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model.

Wada S, Yoshimura K, Hipkiss EL, Harris TJ, Yen HR, Goldberg MV, Grosso JF, Getnet D, Demarzo AM, Netto GJ, Anders R, Pardoll DM, Drake CG. Wada S, et al. Among authors: drake cg. Cancer Res. 2009 May 15;69(10):4309-18. doi: 10.1158/0008-5472.CAN-08-4102. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435909 Free PMC article.

6

Immunotherapy for prostate cancer: an emerging treatment modality.

Drake CG. Drake CG. Urol Clin North Am. 2010 Feb;37(1):121-9, Table of Contents. doi: 10.1016/j.ucl.2009.11.001. Urol Clin North Am. 2010. PMID: 20152525 Free PMC article. Review.

7

Update: immunological strategies for prostate cancer.

Drake CG, Antonarakis ES. Drake CG, et al. Curr Urol Rep. 2010 May;11(3):202-7. doi: 10.1007/s11934-010-0106-8. Curr Urol Rep. 2010. PMID: 20425628 Free PMC article. Review.

8

Anti-tumor effects of endogenous prostate cancer-specific CD8 T cells in a murine TCR transgenic model.

Bruno TC, Rothwell C, Grosso JF, Getnet D, Yen HR, Durham NM, Netto G, Pardoll DM, Drake CG. Bruno TC, et al. Among authors: drake cg. Prostate. 2012 Apr;72(5):514-22. doi: 10.1002/pros.21453. Epub 2011 Jul 14. Prostate. 2012. PMID: 21761425 Free PMC article.

9

Update on prostate cancer vaccines.

Drake CG. Drake CG. Cancer J. 2011 Sep-Oct;17(5):294-9. doi: 10.1097/PPO.0b013e3182325e78. Cancer J. 2011. PMID: 21952278 Free PMC article. Review.

10

Combining immunological and androgen-directed approaches: an emerging concept in prostate cancer immunotherapy.

Antonarakis ES, Drake CG. Antonarakis ES, et al. Among authors: drake cg. Curr Opin Oncol. 2012 May;24(3):258-65. doi: 10.1097/CCO.0b013e32835205a0. Curr Opin Oncol. 2012. PMID: 22410456 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters